期刊文献+

超声定量评价甲状腺结节包膜反应 被引量:2

Ultrasonographic quantitative evaluation of thyroid nodule capsular reaction
下载PDF
导出
摘要 目的探讨超声定量评价甲状腺结节与包膜的关系对于术前评估甲状腺结节良恶性的价值。方法回顾性分析79例经病理证实的、位于甲状腺包膜下肿瘤,分析其与包膜的关系,通过测量结节纵径(自结节包膜交界处至结节最深处,V)及结节凸出甲状腺包膜与突出最高处的距离(L),评价L/V诊断甲状腺恶性结节的效能。结果甲状腺良性和恶性结节平均L/V值分别为0.241±0.041、0.162±0.054,差异有统计学意义(t=-7.367,P<0.01)。L/V诊断甲状腺良恶性结节的ROC曲线下面积为0.87(P<0.01)。L/V=0.225时,诊断甲状腺恶性结节的敏感度为82.17%、特异度为87.53%;L/V=0.245时,诊断甲状腺恶性结节的敏感度为67.10%,特异度为95.12%。结论超声可清晰显示甲状腺结节与包膜的关系,通过测量L/V可鉴别诊断甲状腺结节的良恶性。 Objective To quantitatively observe the value of relationship between nodule and corresponding capsular with ultrasonography in assessment of malignant and benign thyroid nodules. Methods A total of 79 cases with subcapsular tumors of thyroid gland confirmed pathologically were analyzed retrospectively, and the relationship between tumors and capsule was analyzed. Longitudinal diameter of nodules (from the junction of nodule and capsule to the deepest of nodule, V) and distance from nodule protruding thyroid capsule to the highest point of nodule (L) were measured, and L/V was evaluated. Diagnostic efficiency of L/V in diagnosis of malignant thyroid nodule was evaluated. Results The average L/V of benign and malignant nodules was 0.241±0.041 and 0.162±0.054, respectively (t=-7.367, P〈0.01). The area under ROC curve of L/V in diagnosis of benign and malignant thyroid nodules was 0.87 (P〈0.01). When L/V=0.225, the sensitivity was 82.17%, and the specificity was 87.53%; when L/V=0.245, the sensitivity was 67.10%, and the specificity was 95.12%. Conclusion Ultrasonography can clearly show the relationship between thyroid nodules and capsule, and L/V can be used for differential diagnosis of benign and malignant thyroid nodules.
出处 《中国医学影像技术》 CSCD 北大核心 2017年第12期1821-1823,共3页 Chinese Journal of Medical Imaging Technology
关键词 甲状腺 超声检查 病理学 Thyroid gland Ultrasonography Pathology
  • 相关文献

参考文献3

二级参考文献23

  • 1Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2009, 19(11):1167-1214.
  • 2Orell S, Sterret G, Whitaker D, et al. Chapter 6. Thyroid[M]. UK: Elsevier Churchill Livingstone, 2005:125-163.
  • 3Lewis CM, Chang KP, Pitman M, et al. Thyroid fine-needle aspiration biopsy: variability in reporting [J]. Thyroid, 2009, 19(7): 717-723.
  • 4Gharib H, Papini E, Paschke R, et al. American association of clinical endocrinologists, associazione medici endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules [J]. Endocr Pract, 2010, 16 (suppl 1):1-43.
  • 5Camargo R, Corigliano S, Friguglietti C, et al. Latin American thyroid society recommendations for the management of thyroid nodules [J]. Arq Bras Endocrinol Metabnl, 2009, 53(9): 1167-1175.
  • 6Ali SZ, Cibas ES. The bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes [M]. New York: Springer, 2010:1-166.
  • 7Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation [Jl. Cytojournal, 2008, 5 (1):6.
  • 8Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2006, 16(2):109-142.
  • 9Cibas ES, Ali SZ. The Bethesda System For Reporting Thyroid Cytopathology [ J ]. Am J Clin Pathol, 2009, 132(5):658-665.
  • 10Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution[J]. Thyroid, 2009, 19(11):1215-1223.

共引文献275

同被引文献9

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部